Abiopharma

(99% Positive) WM TECHNOLOGY, INC. (MAPSW) Announces Business Combination

Director Pursglove Geordan Garrett 🟡 adjusted position in 0 shares (1 derivative) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) at $2.83 Transaction Date: Apr 15, 2026 | Filing ID: 017855

(99% Neutral) J.JILL, INC. (JILL) Announces Executive Changes

Stazzone Peter 🟡 adjusted position in 0 shares (1 derivative) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) at $4.45 Transaction Date: Apr 15, 2026 | Filing ID: 017857

Director Sawyer Jason David 🟡 adjusted position in 0 shares (1 derivative) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) at $3.59 Transaction Date: Apr 15, 2026 | Filing ID: 017856

Director Holloway Michael Andrew 🟡 adjusted position in 0 shares (1 derivative) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) at $3.59 Transaction Date: Apr 15, 2026 | Filing ID: 017853

Director Primus Guy Warren 🟡 adjusted position in 0 shares (1 derivative) of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) at $4.05 Transaction Date: Apr 15, 2026 | Filing ID: 017854

(99% Neutral) BRANCHOUT FOOD INC. (BOF) Announces Business Combination

(99% Neutral) BOREALIS FOODS INC. (BRLSW) Files Form 8-K

(85% Positive) THERIVA BIOLOGICS, INC. (TOVX) Provides Update on held for San Diego